Related Experiment Video
Updated: May 24, 2026
07:51
Standardized Hemorrhagic Shock Induction Guided by Cerebral Oximetry and Extended Hemodynamic Monitoring in Pigs
Published on: May 21, 2019
Treatment of shock
1Department of Intensive Care, Erasme University Hospital, Université Libre de Bruxelles, Belgium. ddebacke@ulb.ac.be
Acta Clinica Belgica
|February 18, 2012
Summary
Dopamine and norepinephrine are commonly used vasoactive agents for shock, but recent trials suggest dopamine may increase mortality and arrhythmias, especially in cardiogenic shock.
Area of Science:
- Critical Care Medicine
- Pharmacology
- Cardiovascular Physiology
Background:
- Shock is a critical condition characterized by inadequate tissue perfusion.
- Vasoactive agents, including vasopressors and inotropes, are mainstays in managing shock.
- The differential impact of these agents on patient outcomes remains a key research question.
Purpose of the Study:
- To evaluate the clinical relevance of differing hemodynamic and metabolic profiles of vasoactive agents.
- To analyze recent randomized trial data comparing dopamine, norepinephrine, and epinephrine in shock management.
Main Methods:
- Review of recent randomized controlled trials focusing on vasoactive agent use in shock.
- Comparative analysis of hemodynamic and metabolic effects, and patient outcomes.
Main Results:
- Dopamine use is associated with increased tachycardia and arrhythmias, and potentially higher mortality, particularly in cardiogenic shock.
- Norepinephrine has been extensively studied, with outcomes data informing its use.
- Epinephrine's role is less defined, with observed associations with tachycardia, arrhythmias, and adverse metabolic effects.
Conclusions:
- Recent evidence raises significant concerns regarding dopamine's safety profile in shock patients.
- Norepinephrine appears to be a preferred agent in certain shock contexts based on current data.
- Further research is needed to clarify the optimal use of epinephrine and other vasoactive agents.
Related Concept Videos
01:24Blood Pressure Imbalances and Circulatory Shock
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:26Acute Coronary Syndrome V: Nursing Management
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
01:22Methods of reducing fever
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Pharmacological Methods of Reducing Fever: